| Characteristic | Binding partners | Intracellular localization | Tissue distribution | Implication in pathology |
| NOX1 | p22phox, NOXO1, NoxA1, Rac1, PDI, TKS4/5* | Caveolae on the plasma membrane, redoxisomes | Colon epithelia VSMCs, endothelial cells, uterus, placenta, prostate, osteoclasts, retinal pericytes, neurons, astrocytes, microglia | Colon cancer, prostate cancer, gastrointestinal inflammation, hypertension, restenosis after angioplasty | NOX2 | p22phox, p67phox, p40phox, p47phox, Rac1/2 | Phagosomes, cytoskeleton, lamellipodia, redoxisomes | Phagocytes, CNS, endothelium, VSMCs, fibroblasts, cardiomyocytes, skeletal muscle, hepatocytes, hematopoietic stem cells | Gastrointestinal inflammation, hypertension, myocardial injury, restenosis after angioplasty, melanoma, diabetes, neurodegenerative diseases | NOX3 | p22phox, NOXO1 | Plasma membrane | Inner ear, lung endothelial cells, fetal tissues | Hearing loss, pancreatic cancer | NOX4 | p22phox, PDI, TKS4/5, Poldip2* | Focal adhesions, nucleus, endoplasmic reticulum, mitochondria | Ubiquitously expressed but highly in the kidney | Pancreatic cancer, melanoma, diabetes | NOX5 | Ca2+, Hsp90, CaM# | Internal membranes, plasma membrane | Lymphatic tissue, testis, VSMCs, endothelial cells, spleen, uterus, and prostate | Atherosclerosis prostate cancer, pancreatic cancer | Duox1 | Ca2+, DuoxA1 | Plasma membrane | Thyroid, respiratory epithelium | Thyroid dysfunction, cystic fibrosis | Duox2 | Ca2+, DuoxA2 | Plasma membrane | Airway epithelial, colon, salivary gland | Thyroid dysfunction, cystic fibrosis |
|
|